About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Odyssey Therapeutics raises $168M for oncology medicine portfolio

Merck contributing to Jacobio Pharma colorectal cancer clinical trial

T-cell therapy platform trial begins in adults with blood cancers

Skin microbiome research could lead to new approaches for addressing organ damage after stem cell transplants

Inotrem says septic shock trial yields positive results

Adalta and GPCR Therapeutics to collaborate on novel cancer treatments

ADVERTISEMENT

Amolyt Pharma publishes hypoparathyroidism treatment results 

SiSaf takes steps with FDA for RNA therapeutic to treat rare genetic skeletal disorders 

Ascidian Therapeutics launches with $50M to rewrite RNA

Malaysian Genomics signs research agreement with government

Virtual trials growth leads to Cambridge Cognition acquiring eClinicalHealth

Emergex looks to microneedle patches with Zosano Pharma acquisition

ADVERTISEMENT